Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings
Caitlin M. Dugdale(Brown University), Andrea Ciaranello(Harvard University), Genevieve G. Fouda(Durham University), Lynda Stranix‐Chibanda(University of Zimbabwe), Christopher Alba(Harvard University), Coleen K. Cunningham(Duke Medical Center), Sallie R. Permar(Cornell University), Valériane Leroy(Université Toulouse III - Paul Sabatier), Kenneth A. Freedberg(Harvard University), Landon Myer(University of Cape Town), Elizabeth J. McFarland(University of Colorado Anschutz Medical Campus), Milton C. Weinstein(Harvard University), Ogochukwu Ufio(Massachusetts General Hospital)
Cited by 20
Related Papers
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
|New England Journal of Medicine|2001|519
Effectiveness of Pediatric Antiretroviral Therapy in Resource‐Limited Settings: A Systematic Review and Meta‐analysis
|Clinical Infectious Diseases|2009|114